NIFEDIPINE
Nifedipine is a calcium channel blocker causing arterial vasodilation, used for hypertension and angina. Side effects include flushing, edema, headache, and palpitations.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of Action
NIFEDIPINE (ID 26864) displays a broad-spectrum, multilayered biochemical interaction profile involving receptor-mediated signalling, enzymatic cascade modulation, mitochondrial redox-balance control, intracellular ion regulation, cytoskeletal architecture influence, and transcription-factor network modulation. Structural analysis suggests potential binding to catalytic residues, allosteric domains and regulatory scaffolding proteins, enabling the compound to alter phosphorylation–dephosphorylation kinetics, second‑messenger dynamics (Ca²⁺, IP₃, DAG, cAMP), ROS buffering capacity, and membrane-potential stabilization.
Depending on experimental concentration and cellular context, NIFEDIPINE may adjust ATP turnover rates, affect mitochondrial respiration, reshape metabolic routing, influence vesicular trafficking efficiency, and modulate gene‑expression clusters related to cellular survival, stress adaptation, inflammation, and metabolic equilibrium.
Benefits and Advantages
This compound is highly valuable for advanced mechanistic and preclinical research, including:
- High‑resolution receptor–ligand binding and affinity‑mapping studies
- Detailed enzymatic‑kinetic profiling and catalytic‑pathway deconstruction
- Mitochondrial‑function analysis, ATP‑flux tracking and oxidative‑stress modelling
- Integrated multi‑omics investigations (transcriptomics, metabolomics, proteomics, phosphoproteomics)
- Cytoskeletal and membrane‑dynamics analysis involving actin and tubulin regulation
- Apoptosis, autophagy, necroptosis, ferroptosis and other cell‑death pathway studies
- Structure–activity relationship (SAR) assessment and molecular optimisation pipelines
- Advanced pharmacodynamic simulations and mechanistic dose‑response scaling
Side Effects and Risks
Laboratory‑observed risks include:
- Excessive ROS accumulation and oxidative‑stress imbalance
- Mitochondrial hyperactivation or suppression of respiratory‑chain complexes
- Disruption of Ca²⁺/Na⁺/K⁺ ionic homeostasis and channel regulation
- Unintended receptor cross‑talk or inhibitory interference
- Membrane‑integrity compromise and cytoskeletal destabilisation
- Dose‑dependent cytotoxicity leading to apoptosis, autophagy or metabolic collapse
- Inflammatory transcriptional activation (NF‑κB, JNK, p38 MAPK)
Extended exposure may trigger long‑term transcriptional rewiring, metabolic reprogramming or epigenetic instability. Use exclusively within controlled laboratory environments following strict biosafety protocols.
Datasheet
| Molecular Formula | C17H18N2O6 |
|---|---|
| Molecular Weight | 346.3 g/mol |
| CAS Number | 21829-25-4 |
| Storage Condition | Nifedipine liquid-filled capsules should be protected from light and moisture and stored in tight, light-resistant containers at a temperature of 15-25 °C, and extended-release tablets of the drug should be protected from light and moisture and stored in tight, light-resistant containers at a temperature less than 30 °C. |
| Solubility | less than 1 mg/mL at 67.1 °F (NTP, 1992) |
| Purity | Purity information is available upon request (COA). |
| Synonym | nifedipine; 21829-25-4; Procardia; Adalat; Procardia XL |
| IUPAC/Chemical Name | dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
| InChl Key | HYIMSNHJOBLJNT-UHFFFAOYSA-N |
| InChl Code | InChI=1S/C17H18N2O6/c1-9-13(16(20)24-3)15(14(10(2)18-9)17(21)25-4)11-7-5-6-8-12(11)19(22)23/h5-8,15,18H,1-4H3 |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.


